Top compounds associated with response to NMRK2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.1
mRNA SN-38 GDSC1000 pan-cancer AAC -0.055 0.1
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.1
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.1
mRNA Crizotinib CCLE pan-cancer AAC -0.068 0.1
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.052 0.1
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.051 0.1
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.054 0.1
mRNA Imatinib FIMM pan-cancer AAC -0.26 0.1
Download CSV